Quiet hospital rooms, flexible care: why FresuCare swing beds matter

Edited by ad hoc news Flagship & Bestseller Desk. Reviewed before publication on 06/15/2026 at 6:23 PM ET. Details in the imprint.

Hospitals looking to make patient rooms quieter and more flexible are increasingly turning to adjustable "swing beds" such as the FresuCare swing bed from Fresenius. The system is designed so that patients can manually or electrically adjust the bed orientation to balconies or windows while hospital operators keep a handle on costs and room turnover.

How the FresuCare swing bed is built to serve two users at once

The FresuCare swing bed is part of Fresenius' FresuCare room and bed concepts, which combine mechanical swing frames with optional electric drives so that patients can change their lying position and view without staff having to reposition the entire bed. According to the manufacturer, the beds can be configured either as purely manual units with mechanical swing arms or as motorized systems where patients can move the bed at the push of a button, making them suitable for both standard wards and premium rooms. A Helios hospital equipment overview describes swing beds as a way to increase comfort while maintaining standardized room layouts.

Technically, FresuCare swing beds are mounted on a ceiling track or wall-fixed swing arm that allows the bed to rotate within the room footprint while keeping power and medical gas connections accessible. This design is meant to keep headwall equipment in reach and minimize cable clutter even when the patient changes position. The concept supports different mattress systems, including pressure-relief surfaces, which is important for long-stay patients and reduces the risk of pressure ulcers in internal medicine and geriatric wards.

From an operational point of view, swing beds help hospitals use the same room as an intensive-care or intermediate-care space when demand peaks, and as a regular ward bed in quieter periods. Fresenius markets FresuCare as part of an integrated room design that includes medical supply units, bed-head panels and monitoring infrastructure, allowing hospitals to retrofit existing buildings instead of building fully new ICU wings. A case study from a German clinic shows that swing-bed rooms can be reconfigured between observation and normal-care use within minutes, which aids capacity management and reduces the number of transfers per patient.

Noise and light exposure are emerging as quality metrics in many European hospital rating systems, and FresuCare swing beds address these indirectly by letting patients orient away from corridors toward windows or balconies without staff intervention. That can help patients sleep better, especially in multi-bed rooms where one patient’s treatment activities often disturb others. In addition, the ability to reposition the bed quickly makes it easier for staff to use mobile imaging or ultrasound devices at the bedside while still complying with workflow and hygiene standards.

Fresenius integrates the swing-bed concept into wider service contracts that may include maintenance, refurbishment and training, positioning FresuCare not simply as a product but as part of a hospital modernisation package. The group’s hospital subsidiary Helios has rolled out swing-bed room concepts in selected German locations, which the company highlights as reference projects when pitching to other providers in Europe and Latin America. Fresenius' 2023 annual report notes that hospital infrastructure and services remain a strategic focus alongside its dialysis and generic medicines activities.

For a health-care group like Fresenius, swing beds are a relatively small piece of a large portfolio but they tie directly into long-stay care, rehabilitation and hospital-quality initiatives, areas where patient satisfaction scores can influence reimbursement and contracting. As the company works through its broader restructuring and focuses on its core health-care businesses, practical room solutions such as the FresuCare swing bed support its positioning as a systems provider rather than a pure drug or device maker. Shares of Fresenius SE & Co. KGaA (DE0005785604) traded on Xetra at €28.46 on 06/14/2026, according to recent market data. The Frankfurt Stock Exchange lists Fresenius as a member of the DAX index, underlining its role in the European health-care sector.

This article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.